Gilead Sciences, Inc. 13D and 13G filings for Ikena Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 4:22 pm Sale | 2024-12-31 | 13G | Ikena Oncology, Inc. IKNA | GILEAD SCIENCES INC. GILD | 1,521,312 3.600% | -1,410,155 (-48.10%) | Filing |
| 2023-10-19 3:33 pm Purchase | 2023-10-11 | 13G | Ikena Oncology, Inc. IKNA | GILEAD SCIENCES INC. GILD | 2,931,467 6.700% | 2,931,467 (New Position) | Filing |